Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meningococcal C Vaccine Schedules in Canadian Children
NCT00936962Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Jul 2009
- Primary completion
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Meningococcal group C polysaccharide conjugate vaccine in Serogroup C meningococcal disease (MenC), sponsored by University of British Columbia. Started Jul 2009; status: completed.
02
Drugs
Meningococcal group C polysaccharide conjugate vaccine
03
Conditions
Serogroup C meningococcal disease (MenC)
Beyond the preview
Go deeper on NCT00936962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936962.